MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2018 International Congress

    Feasibility of a health game on cognition in Parkinson’s disease: Interim analyses of the Parkin’Play Study

    S. vd Weijer, M. Kuijf, A. Duits, R. Kessels, N. de Vries, S. Köhler, G. Tissingh, B. Bloem (Maastricht, Netherlands)

    Objective: The Parkin'Play Study aims to evaluate the feasibility of an individually tailored multi-domain cognitive intervention (a health game) on cognitive performance in Parkinson's Disease…
  • 2018 International Congress

    Development of evidence-based clinical practice guideline (CPG) of complementary and alternative medicine (CAM) for Parkinson’s disease (PD)

    K.H. Cho, S.W. Kwon, S.H. Lee, T.H. Kim (Seoul, Republic of Korea)

    Objective: The purpose of this CPG was to describe the state of evidence on CAM interventions for PD reflecting current clinical practice. Background: Many patients…
  • 2018 International Congress

    Angiotensin-converting enzyme inhibitors are neuroprotective regarding APOE-mediated motor and non-motor experiences for Alzheimer’s dementia but not for dementia with Lewy bodies

    F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)

    Objective: To assess whether angiotensin-converting enzyme (ACE) inhibitors modulate associations of biofluid concentrations and activity of ACE with motor and non-motor experiences in dementia with…
  • 2018 International Congress

    The Development of Interactive, Video-Based Modules for Movement Disorders Education

    S. Schaefer, L. Vadlamani, P. Juthani (New Haven, CT, USA)

    Objective: To design and implement an online, video-based, interactive curriculum in movement disorders for neurology residents. Background: Much of neurology residency is dedicated to inpatient…
  • 2018 International Congress

    An evaluation of the availability and format of information provided to patients who have a new diagnosis of Parkinson’s disease (PD)

    L. Ebenezer, J. Price, H. Martin (Bridgend, United Kingdom)

    Objective: To evaluate if the information provided to a person with Parkinson’s (PwP) is relevant and appropriate for that individual. To also consider the need…
  • 2018 International Congress

    Reversible asymmetric parkinsonism and vertical gaze limitation as an initial manifestation of dural arteriovenous fistula

    W. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report a case of unusual manifestation of dural arteriovenous fistula (DAVF) which showed reversible asymmetric parkinsonism and vertical gaze limitation…
  • 2018 International Congress

    Effects of the Lee Silverman Voice Treatment (LSVT LOUD ®) on Facial Expressivity in Individuals with Parkinson’s Disease (PD) as a function of Emotional Valence

    A. Bono, K. Scorpio, R. Stafford, M. Halfacre, E. Murray, J. Twaite, K. Alterescu, J. Spielman, A. Halpern, L. Ramig, J. Borod (Flushing, NY, USA)

    Objective: To examine the effect of LSVT LOUD (Ramig et al., 2011) on facial expressivity in PD as a function of emotional valence. Background: Research…
  • 2018 International Congress

    Can choice of games influence the therapeutic results obtained by training in virtual reality for gait improvement in people with Parkinson’s disease?

    P. Barbosa, A. da Costa, A. Falconi, M. d'Alencar, M E. Piemonte (São Paulo, Brazil)

    Objective: The aim of this study was to compare the efficiency of two different combination of games to improve the gait performance in PPD. Background:…
  • 2018 International Congress

    Efficacy of prolonged release melatonin for REM sleep behaviour disorder in Parkinson’s disease: A double blind, randomised, placebo-controlled trial

    M. Gilat, R. Grunstein, N. Marshall, D. Hammond, A. Coeytaux Jackson, A. Mullins, J. Hall, S. (Sydney, Australia)

    Objective: Test the efficacy of prolonged-released melatonin for REM sleep behaviour disorder (RBD) in Parkinson’s disease (PD). Background: Half of all PD patients experience RBD…
  • 2018 International Congress

    A controlled trial of ParkinSong singing groups to improve communication and wellbeing in Parkinson’s disease

    J. Tamplin, A. Vogel, C. Marigliani, F. Baker, M. Morris (Southbank, Australia)

    Objective: To explore the effects of a therapeutic group singing intervention (ParkinSong) on communication and wellbeing outcomes for people living with Parkinson's disease. Background: Communication…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • #24752 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley